In the Netherlands, an ecosystem is growing which promises new business in neurotechnology.  NeuroTech-NL connects industry to universities, hospitals, clinicians and patient organizations during networking events and coordination around public-private partnerships where the end users (i.e., clinicians and patients) are explicitly involved in the translational aspects. The OECD identifies neurotechnology as one of the ten most promising and disruptive technologies of the future. The global market for neurotechnology is expected to reach $14 Billion in 2022 at an annual growth rate of 10%.

NeuroTech-NL is a Strategic Partner of Dutch Top Sector LSH, sharing in the national mission to reduce the burdens for people living with chronic disorders. We understand the need for clinical trials to allow for research innovations to directly benefit patients while at the same time drive economic activity in the Netherlands. Therefore, we support and accelerate clinical trials for novel technology. NeuroTech-NL clinician scientists are open to dialogues surrounding clinical trials.

Industry is encouraged to partner with researchers and clinicians in higher education, as governments are paying increasing attention to the research value chain with the end user in mind. Several public-private initiatives and funding support exist to combine research, with clinical validation, prototyping, and market entry. Companies (SME’s in particular) can receive subsidies to promote research and development in neurotechnology as well as in market validation steps.

NeuroTech-NL is connected with complimentary initiatives surrounding brain and neurological research in the Netherlands, and draws on nearly all research institutes and UMCs in the country. The Netherlands has a strong position in international scientific recognition in neurotechnology, ranked within the top 5 in the world in terms of scientific publications, and is partnered with larger EU initiatives around research infrastructure (EBRAINS) and higher education (NeurotechEU). There is a strong multidisciplinary expertise between research universities, medical centres, and engineering (technical universities) who are used to collaborating with one another, and with industry.  Our founding researchers and clinician scientists are internationally recognized experts in neuroscience, engineering, and patient treatment and care.